| With CKD; n = 57 | CKD Absent; n = 424 | |
---|---|---|---|
(%, 95Â % CI) | (%, 95Â % CI) | ||
 |  | Low risk (n = 277) | Increased risk (n = 147) |
Prevalence | |||
 of TM Use | 70.3 % (50.0–84.9) | 65.3 % (55.2–74.1) | 49.0 % (33.1–65.0) |
 of concurrent TM and Biomedicine Use | 33.2 % (11.4–65.6) | 4.35 % (2.15–8.61) | 10.4 % (4.70–21.6) |
Incidence of TM Use (per year) | Â | Â | Â |
 1–5 times | 54.4 % (33.4–73.9) | 50.5 % (41.3–59.6) | 31.0 % (20.8–43.3) |
 6–10 times | 11.7 % (3.30–33.6) | 7.69 % (4.86–12.0) | 11.5 % (5.50–22.4) |
 >10 times | 4.30 % (0.01–20.7) | 7.07 % (3.78–12.8) | 7.10 % (3.60–13.5) |
Reasons for TM Use | |||
 More Effective | 85.4 % (65.3–94.8) | 81.3 % (72.4–87.8) | 85.3 % (70.1–93.5) |
 Lower Cost | 65.7 % (45.2–81.7) | 58.8 % (44.5–71.7) | 63.0 % (49.7–74.6) |
 Easier to Access | 58.7 % (39.3–75.6) | 66.8 % (58.7–74.0) | 72.7 % (58.0–83.7) |
 Safer | 54.9 % (34.3–74.0) | 39.5 % (30.0–49.8) | 46.0 % (29.1–63.8) |
 More Traditional/Religious | 37.9 % (21.1–58.0) | 31.1 % (23.0–40.7) | 28.9 % (14.8–48.7) |
Modes of Healthcare Access | |||
 Medical Doctors | 99.4 % (94.8–99.9) | 97.7 % (94.0–99.1) | 94.7 % (88.4–97.6) |
 Family and Elders | 53.0 % (33.0–72.1) | 51.9 % (37.9–65.6) | 53.7 % (38.0–68.6) |
 Traditional Healers | 28.7 % (13.8–50.3) | 5.10 % (2.03–12.2) | 6.81 % (3.03–14.6) |
 Pharmacists | 26.8 % (13.1–47.0) | 21.5 % (13.4–32.6) | 14.2 % (4.95–34.6) |
 Herbal Vendors | 11.8 % (3.30–34.6) | 4.29 % (12.8–13.4) | 5.33 % (2.00–13.4) |
 Friends/Neighbors | 10.6 % (4.40–23.3) | 17.0 % (11.0–25.4) | 17.2 % (8.21–32.6) |
TM Use | |||
 for Symptomatic Ailments | 66.7 % (17.3–54.3) | 33.9 % (25.2–43.9) | 42.7 % (30.1–56.2) |
 for Chronic Diseases | 49.6 % (28.6–70.6) | 25.9 % (17.9–35.8) | 26.3 % (14.3–43.4) |
 for Reproductive Illnesses | 45.1 % (23.3–69.1) | 19.7 % (11.6–31.3) | 16.4 % (8.75–28.5) |
 for Malaria/Febrile Illnesses | 64.0 % (44.1–79.9) | 61.9 % (46.9–75.0) | 46.8 % (31.4–62.8) |
 for Spiritual/traditional uses | 16.1 % (8.71–27.9) | 9.30 % (5.13–16.3) | 4.69 % (1.48–13.8) |
 for Neurologic Illnesses | 45.1 % (23.3–69.1) | 19.7 % (11.6–31.3) | 16.4 % (8.75–28.5) |
 for Urogenital Conditions | 35.3 % (17.7–58.0) | 15.8 % (9.39–25.5) | 13.4 % (7.56–22.8) |
 for Cancers | 11.1 % (3.86–28.3) | 17.8 % (7.87–35.4) | 7.64 % (3.16–17.3) |
 for Disease Prevention | 5.17 % (1.75–14.3) | 4.66 % (2.24–9.43) | 6.99 % (2.77–16.5) |
 for Worms/Parasites | 30.7 % (16.0–50.7) | 8.36 % (5.04–13.6) | 17.0 % (10.3–26.8) |
Modes of TM Use | |||
 Mix with water | 91.8 % (82.7–96.3) | 81.6 % (73.3–87.7) | 84.8 % (75.5–91.0) |
 Drink as a tea | 61.6 % (40.8–78.9) | 55.5 % (42.6–67.7) | 65.9 % (54.9–75.3) |
 Drink as a soup | 59.6 % (39.4–77.0) | 42.9 % (32.6–54.4) | 47.5 % (37.6–57.5) |
 Chew from the plant | 38.4 % (21.2–59.1) | 56.3 % (46.1–66.1) | 59.1 % (43.9–72.8) |
 Drink with milk | 33.2 % (15.4–57.5) | 20.7 % (14.5–28.5) | 24.3 % (16.0–35.1) |
 Bath | 33.5 % (14.6–59.7) | 25.5 % (17.8–35.0) | 31.8 % (16.8–51.9) |
 Inhalation | 49.3 % (27.7–71.1) | 30.2 % (20.0–42.8) | 42.4 % (29.7–56.1) |
 Powders | 19.5 % (2.85–48.5) | 15.0 % (9.75–22.2) | 26.5 % (12.4–47.9) |
 As foods to be eaten | 2.40 % (0.51–10.6) | 3.64 % (1.31–9.67) | 2.96 % (0.76–10.8) |
 Pill/Vitamin form | 2.59 % (0.60–10.5) | 0.63 % (0.19–2.05) | 0.85 % (0.20–3.46) |
 Lotions/Creams | 1.21 % (0.26–5.50) | 6.05 % (3.06–11.6) | 7.81 % (3.10–18.3) |